HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Vijaya Ramesh Selected Research
Vijaya Ramesh Research Topics
Disease
21
Neoplasms (Cancer)
01/2022 - 11/2002
14
Tuberous Sclerosis (Bourneville's Disease)
01/2021 - 11/2003
12
Meningioma (Meningiomas)
01/2021 - 02/2008
6
Neurofibromatosis 2 (Neurofibromatosis Type II)
01/2021 - 11/2004
5
Neurilemmoma (Schwannoma)
01/2021 - 08/2009
4
Neurofibromatoses (Neurofibromatosis)
01/2019 - 02/2010
2
Autism Spectrum Disorder
01/2020 - 03/2013
2
Carcinogenesis
01/2018 - 02/2008
2
Schwannomatosis
06/2017 - 03/2014
2
Chordoma
03/2009 - 09/2004
2
Hamartoma
09/2004 - 11/2003
2
Dystonia (Limb Dystonia)
05/2004 - 02/2003
1
Leukemia
01/2021
1
Frontotemporal Dementia (Semantic Dementia)
01/2021
1
Tauopathies
01/2021
1
Neurodevelopmental Disorders
01/2020
1
Acoustic Neuroma (Acoustic Neurinoma)
01/2020
1
Intellectual Disability (Idiocy)
01/2020
1
Epilepsy (Aura)
01/2020
1
Glioma (Gliomas)
06/2017
1
Neuroblastoma
06/2017
1
Sarcoma (Soft Tissue Sarcoma)
06/2017
1
Weight Gain
10/2015
1
Autistic Disorder (Autism)
03/2013
1
Cognitive Dysfunction
08/2008
1
Movement Disorders (Movement Disorder)
05/2004
1
Inflammation (Inflammations)
02/2003
1
Dystonia musculorum deformans type 1
02/2003
1
Neurologic Manifestations (Neurological Manifestations)
11/2002
Drug/Important Bio-Agent (IBA)
11
trans-sodium crocetinate (crocetin)
IBA
01/2021 - 11/2003
11
Neurofibromin 2 (Merlin)
IBA
01/2018 - 11/2004
11
Proteins (Proteins, Gene)
FDA Link
07/2015 - 02/2003
8
Mechanistic Target of Rapamycin Complex 1
IBA
01/2020 - 03/2009
7
Sirolimus (Rapamycin)
FDA Link
01/2020 - 08/2008
6
Tuberous Sclerosis Complex 2 Protein
IBA
01/2021 - 11/2002
5
Phosphotransferases (Kinase)
IBA
01/2021 - 05/2012
4
Tuberous Sclerosis Complex 1 Protein
IBA
01/2021 - 11/2002
4
TOR Serine-Threonine Kinases
IBA
01/2018 - 06/2008
3
Pharmaceutical Preparations
IBA
01/2021 - 01/2018
3
Mechanistic Target of Rapamycin Complex 2
IBA
01/2018 - 05/2012
3
Tumor Suppressor Proteins (Proteins, Tumor Suppressor)
IBA
07/2015 - 11/2004
2
vistusertib
IBA
01/2020 - 07/2015
2
EphA1 Receptor (Eph Receptor)
IBA
01/2020 - 01/2018
2
Dasatinib (BMS 354825)
FDA Link
01/2020 - 01/2018
2
DNA (Deoxyribonucleic Acid)
IBA
01/2016 - 02/2003
2
Mediator Complex
IBA
01/2015 - 11/2007
2
Biological Products
IBA
08/2008 - 02/2008
2
radixin
IBA
08/2005 - 11/2004
1
Chromatin
IBA
01/2022
1
Adenosine Triphosphate (ATP)
IBA
01/2022
1
Ligands
IBA
01/2021
1
brigatinib
IBA
01/2021
1
Neuregulin-1 (Neuregulin 1)
IBA
01/2021
1
Neuregulins
IBA
01/2021
1
Microtubule-Associated Proteins (Microtubule-Associated Protein 2)
IBA
01/2021
1
Tyrosine (L-Tyrosine)
FDA Link
01/2021
1
tau Proteins (tau Protein)
IBA
01/2021
1
Therapeutic Uses
IBA
01/2020
1
Tyrosine Kinase Inhibitors
IBA
01/2020
1
Drug Combinations
IBA
01/2018
1
omipalisib
IBA
01/2018
1
Panobinostat
IBA
01/2018
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2018
1
Biomarkers (Surrogate Marker)
IBA
06/2017
1
Uvitex SWN (SWN)
IBA
06/2017
1
Vimentin
IBA
01/2016
1
MTOR Inhibitors
IBA
07/2015
1
serum-glucocorticoid regulated kinase
IBA
07/2015
1
FRAX597
IBA
07/2015
1
Elements
IBA
02/2011
1
Phosphatidylinositols (Phosphatidylinositol)
IBA
08/2009
1
PTEN Phosphohydrolase (PTEN Phosphatase)
IBA
03/2009
1
Tensins
IBA
03/2009
1
ezrin
IBA
11/2004
1
moesin
IBA
11/2004
1
Glutamic Acid (Glutamate)
FDA Link
05/2004
1
Kinesins
IBA
05/2004
1
Mitogen-Activated Protein Kinases
IBA
02/2004
Therapy/Procedure
11
Therapeutics
01/2021 - 05/2012
3
Drug Therapy (Chemotherapy)
01/2021 - 02/2010
1
Aftercare (After-Treatment)
01/2018